People who use drugs, HIV, and human rights

Jürgens, Ralf; Csete, Joanne; Amon, Joseph J; Baral, Stefan; Beyrer, Chris

doi:10.1016/s0140-6736(10)60830-6

Cited by 159 publications

(123 citation statements)

References 64 publications

Supporting

Mentioning

114

Contrasting

Order By: Relevance

“…In that study, positive experiences reported included receiving equal treatment, being valued as a partner in one's health, social support provision, and confidentiality assurances while negative experiences included awkward interactions, irrelevant questions, rude treatment, blame, pity, excessive or differential precautions, care refusal, unnecessary referrals, delayed treatment, poor support, and confidentiality breaches. Our current findings are also similar to findings from studies that have investigated health care provision to substance users more generally [6,[36][37][38] as well as studies looking at the interactions between health care providers and substance users with HIV specifically [18][19][20]27]. For example, previous research has shown that substance users have been refused services or prescriptions [6], that substance users have been provided with less information than others and have received poorer quality care [37], and that HIV diagnoses have been provided to substance users in a detached and unsympathetic manner [18].…”

Section: Discussionsupporting

confidence: 90%

See 1 more Smart Citation

Stigma in the Dutch Health Care Sector: HIV-Positive Substance Users’ Experiences and Health Care Providers’ Perspectives

Stutterheim¹,

Roberts²,

Baas³

et al. 2017

ARC Journal of Nursing and Healthcare

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 90%

“…These kinds of macro supports for interpersonal and organizational interventions are imperative if interventions are to be successful. Interventions should also be characterized by target user participation [11,36,38,48].…”

Section: Discussionmentioning

confidence: 99%

Stigma in the Dutch Health Care Sector: HIV-Positive Substance Users’ Experiences and Health Care Providers’ Perspectives

Stutterheim¹,

Roberts²,

Baas³

et al. 2017

ARC Journal of Nursing and Healthcare

View full text Add to dashboard Cite

“…8 Yet doubts about the wisdom of providing opioid substitution therapy to injecting drug users are widespread in developing countries, where abstinence is often seen as the only legitimate treatment goal, and human rights are frequently violated in attempts to achieve this. 9 Barriers to effective implementation of opioid substitution therapy programmes in these settings include: a lack of political will to act; the need to change relevant laws; entrenched social and structural discrimination against injecting drug users; the cost of providing the therapy (despite the ample evidence of cost-effectiveness); 10 and the relative lack of local evidence for effectiveness in resource-poor settings.…”

mentioning

confidence: 99%

Opioid substitution therapy in resource-poor settings

Kermode

Crofts

Kumar³

et al. 2011

Bull. World Health Organ.

View full text Add to dashboard Cite

“…abuses and vulnerability to HIV infection in The Lancet, Jürgens et al (2010) states that a rights-based response to drug use must be taken.…”

Section: Introductionmentioning

confidence: 99%

The injecting ‘event’: harm reduction beyond the human

Dennis

2017

Critical Public Health

View full text Add to dashboard Cite

Since the 1980s, the primary public health response to injecting drug use in the UK has been one of harm reduction. That is, reducing the harms associated with drug use without necessarily reducing consumption itself. Rooted in a post-Enlightenment idea of rationalism, interventions are premised on the rational individual who, given the right means, will choose to avoid harm. This lies in stark contrast to dominant addiction models that pervade popular images of the 'out of control' drug user, or worse, 'junkie'. Whilst harm reduction has undoubtedly had vast successes, including challenging the otherwise pathologising and often stigmatising model of addiction, I argue that it has not gone far enough in addressing aspects of drug use that go beyond 'rational' and 'human' control. Drawing on my doctoral research with people who inject drugs, conducted in London, UK, this paper highlights the role of the injecting 'event', which far from being directed or controlled by a pre-defined individual or 'body' was composed by a fragile assemblage of bodies, human and nonhuman. Furthermore, in line with the 'event's' heterogeneous and precarious make-up, multiple ways of 'becoming' through these events were possible. I look here at these 'becomings' as both stabilising and destabilising ways of being in the world, and argue that we need to pay closer attention to these events and what people are actually in the process of becoming in order to enact more accountable and 'response-able' harm reduction.

show abstract

People who use drugs, HIV, and human rights

Cited by 159 publications

References 64 publications

Stigma in the Dutch Health Care Sector: HIV-Positive Substance Users’ Experiences and Health Care Providers’ Perspectives

Stigma in the Dutch Health Care Sector: HIV-Positive Substance Users’ Experiences and Health Care Providers’ Perspectives

Opioid substitution therapy in resource-poor settings

The injecting ‘event’: harm reduction beyond the human

Contact Info

Product

Resources

About